MBL or CLL: Which Classification Best Categorizes the Clinical Course of Patients with an Absolute Lymphocyte Count ≥5 × 10(9)/L but a B-cell Lymphocyte Count <5 × 10(9)/L?

द्वारा Shanafelt, Tait D., Kay, Neil E., Call, Tim G., Zent, Clive S., Jelinek, Diane F., LaPlant, Betsy, Morice, William G., Hanson, Curtis A.
प्रकाशित 2008

Brief Report: Pre-treatment Angiogenic Cytokines Predict Response to Chemoimmunotherapy in Patients with CLL

द्वारा Shanafelt, Tait D., Byrd, John C., LaPlant, Betsy, Zent, Clive S., Call, Tim, Secreto, Charla, Grever, Michael R., Lin, Thomas S., Kay, Neil E.
प्रकाशित 2009

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

द्वारा Shanafelt, Tait D., Geyer, Susan M., Bone, Nancy D., Tschumper, Renee C., Witzig, Tom E., Nowakowski, Greg S., Zent, Clive S., Call, Tim G., LaPlant, Betsy, Dewald, Gordon W., Jelinek, Diane F., Kay, Neil E.
में प्रकाशित Br J Haematol (2008)

Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia

द्वारा Shanafelt, Tait D., Call, Tim G., Zent, Clive S., LaPlant, Betsy, Bowen, Deborah A., Roos, Michelle, Secreto, Charla R., Ghosh, Asish K., Kabat, Brian F., Lee, Mao-Jung, Yang, Chung S., Jelinek, Diane F., Erlichman, Charles, Kay, Neil E.
प्रकाशित 2009

Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL)

द्वारा Shanafelt, Tait D., Call, Tim G., Zent, Clive S., Leis, Jose F., LaPlant, Betsy, Bowen, Deborah A., Roos, Michelle, Laumann, Kristina, Ghosh, Asish K., Lesnick, Connie, Lee, Mao-Jung, Yang, Chung S., Jelinek, Diane F., Erlichman, Charles, Kay, Neil E.
प्रकाशित 2012

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy

द्वारा Sinha, Sutapa, Boysen, Justin C., Chaffee, Kari G., Kabat, Brian F., Slager, Susan L., Parikh, Sameer A., Secreto, Charla R., Call, Tim, Shanafelt, Tait D., Leis, Jose F., Warner, Steven L., Bearss, David J., Ghosh, Asish K., Kay, Neil E.
में प्रकाशित Oncotarget (2018)

Akt inhibitor MK-2206 in combination with Bendamustine and Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results from the N1087 Alliance Study

द्वारा Larsen, Jeremy T., Shanafelt, Tait D., Leis, Jose F., LaPlant, Betsy, Call, Tim, Pettinger, Adam, Hanson, Curtis, Erlichman, Charles, Habermann, Thomas Matthew, Reeder, Craig, Nikcevich, Daniel, Bowen, Deborah, Conte, Michael, Boysen, Justin, Secreto, Charla, Lesnick, Connie, Tschumper, Renee, Jelinek, Diane, Kay, Neil E., Ding, Wei
में प्रकाशित Am J Hematol (2017)